Foresite Capital Management Iv, LLC Fulcrum Therapeutics, Inc. Transaction History

Foresite Capital Management Iv, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$7.22 - $20.7 $8.19 Million - $23.5 Million	-1,133,948 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$9.11 - $22.06 $1.23 Million - $2.98 Million	135,293 Added 13.55%	1,133,948 $20.7 Million
Q1 2020 May 14, 2020	SELL	$9.49 - $21.26 $4.76 Million - $10.7 Million	-501,345 Reduced 33.42%	998,655 $11.9 Million
Q4 2019 Feb 14, 2020	SELL	$4.46 - $18.14 $836,250 - $3.4 Million	-187,500 Reduced 11.11%	1,500,000 $25 Million
Q3 2019 Nov 13, 2019	BUY	$6.64 - $14.89 $11.2 Million - $25.1 Million	1,687,500 New	1,687,500 $11.2 Million

136

59.2M

4.33M

309K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $169M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.